Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesStrong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease
Journal of Oncology, 06/12/09
Wehler TC et al. - In a study to evaluate the influence of CXCR4 expression on the progression of human renal cell carcinoma (RCC), it was shown that strong CXCR4 expression was significantly associated with advanced dedifferentiated RCC.
Methods- CXCR4 expression of RCC was assessed by immunohistochemistry in 113 pts.
- Intensity of CXCR4 expression was correlated with both tumor and pt characteristics.
- Human RCC revealed variable intensities of CXCR4 expression.
- Strong CXCR4 expression of RCC was significantly associated with advanced T-status, tumor dedifferentiation, and low hemoglobin.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pseudopheochromocytoma: An uncommon cause of malignant hypertension
Indian Journal of Nephrology, 10/16/09
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09
Article Search
Sponsor